"10.1371_journal.pone.0012122","plos one","2010-08-11T00:00:00Z","Alison L McCormack; Sally K Mak; Jaimie M Henderson; David Bumcrot; Matthew J Farrer; Donato A Di Monte","German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; SRI International, Menlo Park, California, United States of America; The Parkinson's Institute, Sunnyvale, California, United States of America; Stanford University, Stanford, California, United States of America; Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America; Mayo Clinic College of Medicine, Jacksonville, Florida, United States of America","Conceived and designed the experiments: ALM DB MJF DADM. Performed the experiments: ALM SKM JMH MJF DADM. Analyzed the data: ALM SKM MJF DADM. Contributed reagents/materials/analysis tools: JMH DB. Wrote the paper: ALM DADM.","One of the authors (D.B.) is an employee of Alnylam Pharmaceuticals, a for-profit company focused on the development of RNA interference-based therapeutics.","2010","08","Alison L McCormack","ALMC",6,TRUE,4,5,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
